⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10378132 | 0.84 | — | — | |
| SCHEMBL7322366 | 0.81 | — | — | |
| SCHEMBL4349103 | 0.79 | — | — | |
| SCHEMBL17436856 | 0.78 | EPHX1 (0.43) | — | |
| SCHEMBL1701326 | 0.77 | HPGD (0.46) | — | |
| SCHEMBL2107954 | 0.77 | — | — | |
| SCHEMBL10458964 | 0.76 | — | — | |
| SCHEMBL17407236 | 0.76 | — | — | |
| SCHEMBL3807241 | 0.75 | EPHX1 (0.47) | — | |
| SCHEMBL11608066 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001040244-A1 | N6 HETEROCYCLIC 5' MODIFIED ADENOSINE DERIVATIVES | CV THERAPEUTICS, INC. (US) | 2001-06-07 | — | — | WO | claimed |
| CN-114867529-B | Novel heteroaryl triazole compounds as pesticides | 拜耳公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-117567338-A | Novel heteroaryl triazole compounds as pesticides | 拜耳公司 | 2024-02-20 | — | — | CN | disclosed |
| US-20170027919-A1 | Method for the Treatment of Neurological Disorders by Enhancing the Activity of Beta-Glucocerebrosidase | AMICUS THERAPEUTICS INC (US) | 2017-02-02 | — | — | US | disclosed |
| US-9402837-B2 | Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase | AMICUS THERAPEUTICS, INC. (US) | 2016-08-02 | — | — | US | disclosed |
| US-9119845-B2 | Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase | Amicus Therapeautics, Inc. (US) | 2015-09-01 | — | — | US | disclosed |
| US-20150025109-A1 | Method for the Treatment of Neurological Disorders by Enhancing the Activity of Beta-Glucocerebrosidase | AMICUS THERAPEUTICS INC (US) | 2015-01-22 | — | — | US | disclosed |
| US-20110245258-A1 | NOVEL ANTIMICROBIALS | PANACEA BIOTEC LTD. (IN) | 2011-10-06 | — | — | US | disclosed |
| WO-2001040245-A1 | N6 HETEROCYCLIC 5' MODIFIED ADENOSINE DERIVATIVES | CV THERAPEUTICS, INC. (US) | 2001-06-07 | — | — | WO | disclosed |
| EP-0183848-B1 | POLYAZAHETEROCYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITION | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1990-09-12 | — | — | EP | disclosed |
| US-4918074-A | CALCIUM ANTAGONISTS | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1990-04-17 | — | — | US | disclosed |
| EP-0217142-A2 | A polyazaheterocyclic compound | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1987-04-08 | — | — | EP | disclosed |
| EP-0183848-A1 | POLYAZAHETEROCYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITION | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1986-06-11 | — | — | EP | disclosed |